LENSAR, Inc. (LNSR)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

LENSAR, Inc. (LNSR) is down 56.9% since the beginning of the year. At $5 per share, LNSR is trading 62.0% below its 52-week high of $13. Investors who bought $1,000 worth of LNSR shares 5 years ago would now be looking at an investment worth $616.

LENSAR, Inc. (LNSR) has returned -56.92% so far this year and -60.27% over the past 12 months.

Based on dividend-adjusted daily data since Oct 2, 2020, LNSR's average daily return is +0.18%, while the average monthly return is +3.65%. At this rate, an investment would double in approximately 1.6 years.

Historically, 41% of months were positive and 59% were negative. The best month was Oct 2020 with a return of +208.9%, while the worst month was Mar 2026 at -50.2%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 6 months.

On a daily basis, LNSR closed higher 47% of trading days. The best single day was Oct 2, 2020 with a return of +184.8%, while the worst single day was Mar 17, 2026 at -32.9%.

LENSAR, Inc. has an annualized alpha of 47.34%, beta of 0.36, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since October 02, 2020.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (25.00%) than losses (6.38%) - typical of diversified or defensive assets.
• Beta of 0.36 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

LNSR ranks 3 for risk / return — above 3% of stocks peers on PortfoliosLab. Its historical combined result is below most peers; review the five component ranks for context.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the LENSAR, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the LENSAR, Inc. was 83.52%, occurring on Nov 8, 2023. Recovery took 326 trading sessions.

The current LENSAR, Inc. drawdown is 70.30%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of LENSAR, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how LENSAR, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.